U.S. markets close in 6 hours 16 minutes

BMO Capital Sticks to Their Hold Rating for National Health Investors

BMO Capital analyst John Kim maintained a Hold rating on National Health Investors (NYSE:NHI) on Tuesday, setting a price target of $77, which is approximately 46.11% above the present share price of $52.7.

Kim expects National Health Investors to post earnings per share (EPS) of $0.95 for the second quarter of 2020.

The current consensus among 4 TipRanks analysts is for a Hold rating of shares in National Health Investors, with an average price target of $60.
The analysts price targets range from a high of $82 to a low of $43.

In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $82.2 million and a net profit of $57.17 million. The company's market cap is $2.35 billion.

According to TipRanks.com, BMO Capital analyst John Kim is a 4-star analyst with an average return of 1.7% and a 50.1% success rate.

National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.